2ocw: Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Secretory component (SC) in association with polymeric IgA (pIgA) forms, secretory IgA, the major antibody active at mucosal surfaces. SC also, exists in the free form, with innate-like neutralizing properties against, pathogens. Free SC consists of five glycosylated variable (V)-type Ig, domains (D1-D5), whose structure was determined by x-ray and neutron, scattering, ultracentrifugation, and modeling. With a radius of gyration, of 3.53-3.63 nm, a length of 12.5 nm, and a sedimentation coefficient of, 4.0 S, SC possesses an unexpected compact structure. Constrained, scattering modeling based on up to 13,000 trial models shows that SC, adopts a J-shaped structure in which D4 and D5 are folded back against D2, and D3. The seven glycosylation sites are located on one side of SC, leaving known IgA-binding motifs free to interact with pIgA. This work, represents the first analysis of the three-dimensional structure of, full-length free SC and paves the way to a better understanding of the, association between SC and its potential ligands, i.e. pIgA and, pathogenic-associated motifs.
Secretory component (SC) in association with polymeric IgA (pIgA) forms secretory IgA, the major antibody active at mucosal surfaces. SC also exists in the free form, with innate-like neutralizing properties against pathogens. Free SC consists of five glycosylated variable (V)-type Ig domains (D1-D5), whose structure was determined by x-ray and neutron scattering, ultracentrifugation, and modeling. With a radius of gyration of 3.53-3.63 nm, a length of 12.5 nm, and a sedimentation coefficient of 4.0 S, SC possesses an unexpected compact structure. Constrained scattering modeling based on up to 13,000 trial models shows that SC adopts a J-shaped structure in which D4 and D5 are folded back against D2 and D3. The seven glycosylation sites are located on one side of SC, leaving known IgA-binding motifs free to interact with pIgA. This work represents the first analysis of the three-dimensional structure of full-length free SC and paves the way to a better understanding of the association between SC and its potential ligands, i.e. pIgA and pathogenic-associated motifs.
 
==Disease==
Known disease associated with this structure: IgA nephropathy, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=173880 173880]]


==About this Structure==
==About this Structure==
Line 15: Line 18:
[[Category: Bonner, A.]]
[[Category: Bonner, A.]]
[[Category: Corthesy, B.]]
[[Category: Corthesy, B.]]
[[Category: Perkins, S.J.]]
[[Category: Perkins, S J.]]
[[Category: Perrier, C.]]
[[Category: Perrier, C.]]
[[Category: antibody]]
[[Category: antibody]]
Line 24: Line 27:
[[Category: structure]]
[[Category: structure]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 14:47:49 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:17:04 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA